Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 3
2009 8
2010 18
2011 33
2012 33
2013 15
2014 4
2015 8
2016 4
2017 2
2018 6
2019 9
2020 8
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22974889

141 results
Results by year
Filters applied: . Clear all
Page 1
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?
Vitale A, Boccagni P, Kertusha X, Zanus G, D'Amico F, Lodo E, Pastorelli D, Ramirez Morales R, Lombardi G, Senzolo M, Burra P, Cillo U. Vitale A, et al. Transplant Proc. 2012 Sep;44(7):1989-91. doi: 10.1016/j.transproceed.2012.06.046. Transplant Proc. 2012. PMID: 22974889
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.
Weinmann A, Niederle IM, Koch S, Hoppe-Lotichius M, Heise M, Düber C, Schuchmann M, Otto G, Galle PR, Wörns MA. Weinmann A, et al. Dig Liver Dis. 2012 May;44(5):432-7. doi: 10.1016/j.dld.2011.12.009. Epub 2012 Jan 20. Dig Liver Dis. 2012. PMID: 22265328
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR. Wörns MA, et al. J Clin Gastroenterol. 2009 May-Jun;43(5):489-95. doi: 10.1097/MCG.0b013e31818ddfc6. J Clin Gastroenterol. 2009. PMID: 19247201
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.
Gomez-Martin C, Bustamante J, Castroagudin JF, Salcedo M, Garralda E, Testillano M, Herrero I, Matilla A, Sangro B. Gomez-Martin C, et al. Liver Transpl. 2012 Jan;18(1):45-52. doi: 10.1002/lt.22434. Liver Transpl. 2012. PMID: 21932373 Free article. Clinical Trial.
Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
Yoon DH, Ryoo BY, Ryu MH, Lee SG, Hwang S, Suh DJ, Lee HC, Kim TW, Ahn CS, Kim KH, Moon DB, Kang YK. Yoon DH, et al. Jpn J Clin Oncol. 2010 Aug;40(8):768-73. doi: 10.1093/jjco/hyq055. Epub 2010 May 21. Jpn J Clin Oncol. 2010. PMID: 20494947
Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M, Sieghart W, Graziadei I, Vogel W, Maieron A, Königsberg R, Weissmann A, Kornek G, Plank C, Peck-Radosavljevic M. Pinter M, et al. Oncologist. 2009 Jan;14(1):70-6. doi: 10.1634/theoncologist.2008-0191. Epub 2009 Jan 14. Oncologist. 2009. PMID: 19144684 Free article.
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.
Yau T, Chan P, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT. Yau T, et al. Cancer. 2009 Jan 15;115(2):428-36. doi: 10.1002/cncr.24029. Cancer. 2009. PMID: 19107763 Free article. Clinical Trial.
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.
Zavaglia C, Airoldi A, Mancuso A, Vangeli M, Viganò R, Cordone G, Gentiluomo M, Belli LS. Zavaglia C, et al. Eur J Gastroenterol Hepatol. 2013 Feb;25(2):180-6. doi: 10.1097/MEG.0b013e328359e550. Eur J Gastroenterol Hepatol. 2013. PMID: 23044808 Review.
Clinical course of sorafenib treatment in patients with hepatocellular carcinoma.
Woo HY, Heo J, Yoon KT, Kim GH, Kang DH, Song GA, Cho M. Woo HY, et al. Scand J Gastroenterol. 2012 Jul;47(7):809-19. doi: 10.3109/00365521.2012.683040. Epub 2012 May 8. Scand J Gastroenterol. 2012. PMID: 22563643
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
Rimassa L, Santoro A. Rimassa L, et al. Expert Rev Anticancer Ther. 2009 Jun;9(6):739-45. doi: 10.1586/era.09.41. Expert Rev Anticancer Ther. 2009. PMID: 19496710
141 results
Jump to page
Feedback